Linked Life Data

16366373

Source:http://linkedlifedata.com/resource/pubmed/id/16366373

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11 Suppl 4
pubmed:dateCreated
2005-12-21
pubmed:abstractText
Although resection currently remains the standard of care for renal carcinoma, the search for less invasive treatments has led to alternative surgical approaches. Even less invasive, and appropriate for many groups of patients, is percutaneous radiofrequency ablation, which induces tumor necrosis via lethal hyperthermia. Multiple series of renal tumors treated with percutaneous ablation in vivo and left in situ have been published; these series reveal that for small renal tumors, radiofrequency ablation results in complete necrosis at imaging in 79% to 100% of cases. Because current results come from tumors left in situ with short postablation follow-up, long-term results are necessary to compare outcomes to surgical standards. Complication rates are lower than those following partial nephrectomy. Future reports will shed light on the long-term outcomes of percutaneous ablation and the relative advantages and disadvantages of various technologies for thermal ablation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0890-9091
pubmed:author
pubmed:issnType
Print
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6-11
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Percutaneous ablation of kidney tumors in nonsurgical candidates.
pubmed:affiliation
Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Boston 02114, USA. dgervais@partners.org
pubmed:publicationType
Journal Article, Review, Historical Article